Oncology drug trials in Rochester, New York

Southern Tier Oncology LLC, located at 21 Orchard Street in Hornell, New York, is a leading institution in cancer care. Dr. Neeta Soni, a board-certified medical oncologist, has joined UR Medicine’s Wilmot Cancer Institute as Associate Professor of Clinical Medicine. Dr. Soni and her team have been providing excellent and compassionate care to the Olean area since 2003, and they are now expanding their services to Wellsville as well. Patients at Southern Tier Oncology LLC have access to a wide range of cancer treatments, including chemotherapy infusion services. By partnering with Wilmot Cancer Institute, patients can benefit from additional access to clinical trials and support services. Dr. Soni's expertise and experience in oncology care have been well-received by the community, with Jones Memorial Hospital CEO Eva Benedict expressing excitement about the increased access to quality cancer care. With Dr. Soni as part of the team, patients in Cattaraugus and Allegany Counties can continue to receive high-quality cancer care closer to home. Dr. Soni's extensive medical background, including a medical degree from Byramjee Jeejeebhoy Medical College in India and a fellowship in medical oncology at Roswell Park, ensures that patients at Southern Tier Oncology LLC receive top-notch care.

The Lipson Cancer Institute - Unity Professional Office Building is a leading healthcare facility located at 1561 Long Pond Road in Rochester, New York. As a renowned cancer institute, they provide top-notch medical care and cutting-edge treatments for patients battling cancer. Their team of skilled healthcare professionals are dedicated to delivering personalized and comprehensive care to each patient. With state-of-the-art facilities and a commitment to excellence, the Lipson Cancer Institute is a beacon of hope for those in need of cancer treatment in the United States.

Deepak Sahasrabudhe, MD is a reputable institution located at 601 Elmwood Avenue in Rochester, New York, United States. Dr. Sahasrabudhe is a board-certified physician specializing in Internal Medicine and Medical Oncology, with extensive experience in the field. He is also a Professor in the Department of Medicine, Hematology/Oncology at the School of Medicine and Dentistry. Dr. Sahasrabudhe completed his fellowship at the University of Rochester Medical Center and the University of North Carolina Hospitals, as well as his residency and internship at Albany Medical Center Hospital. He earned his MBBS degree from Topiwala National Medical College in India. The institution is currently involved in various research studies, including clinical trials for experimental drugs and treatments for renal cell carcinoma and other types of cancer. Dr. Sahasrabudhe has published numerous articles in reputable medical journals and has contributed significantly to the field of oncology. Patients can trust Dr. Sahasrabudhe and his team for high-quality, compassionate care and the latest advancements in cancer treatment.

Bingren Liu, BMed is a doctor specializing in clinical radiation oncology located at 262 Bank Street, Batavia, New York, United States. As an Associate Professor of Clinical Radiation Oncology at the Department of Radiation Oncology, Liu has a background in residency in Radiation Oncology from Ohio State University Wexner Medical Center and Internal Medicine from Long Island College Hospital. His research includes studies on prostate brachytherapy, cisplatin resistance, DNA repair regulation, and multidrug resistance in leukemia. At URMC, transparency and patient empowerment are key values, with patient feedback through Press Ganey surveys being used to provide star ratings and anonymous comments on providers to help patients make informed decisions about their healthcare.

Patrick Reagan, MD is a renowned doctor specializing in Hematology/Oncology, located at 601 Elmwood Avenue in Rochester, New York, United States. Dr. Reagan is an Associate Professor in the Department of Medicine at the University of Rochester Medical Center, with extensive training and experience in internal medicine and oncology. He has received numerous awards and recognitions for his contributions to cancer research and patient care. Dr. Reagan's clinical practice focuses on treating patients with high-risk large B-cell lymphoma, utilizing cutting-edge therapies such as chimeric antigen receptor (CAR) T-cell therapy. He is currently involved in several clinical trials testing the effectiveness and safety of novel drugs for patients with relapsed or refractory B-cell lymphoma.